# V1 Empirics Check — openai/gpt-oss-120b (Variant B)

**Model:** openai/gpt-oss-120b
**Variant:** B
**Date:** 2026-03-22T14:03:55.078133

---

**1. Idea Fidelity**  
The paper follows the original manifest closely. It uses the CDC COMEC classification of county‑level medicolegal death‑investigation (MDI) systems, merges those data with the NCHS model‑based drug‑overdose mortality estimates, and exploits within‑state border‑county pairs to identify the causal effect of having an elected coroner versus an appointed medical examiner on the measured opioid‑overdose death rate. The identification strategy (border‑pair design with state fixed effects, randomization‑inference checks, and falsification tests) and the primary outcome (share of unspecified drug‑poisoning deaths / overall overdose rate) match the proposal. The only minor deviation is that the paper reports the outcome in terms of the *overall* age‑adjusted overdose rate rather than the explicit share of T50.9 “unspecified” deaths; however, the author justifies this by the lack of publicly available ICD‑10‑level data at the county level and argues that the net effect on the total rate captures the same measurement error. This is a reasonable compromise and does not undermine the core research question.

---

**2. Summary**  
The paper provides the first causal estimate of how the professionalization of death investigation (coroner vs. medical examiner) biases county‑level opioid‑overdose mortality statistics. Using a border‑county pair design across 13 mixed‑system states, the author finds that coroner counties under‑report drug‑overdose deaths by roughly 2.5 per 100 000 population—a gap that widens in the fentanyl era and translates into an estimated 2,300‑plus uncounted deaths annually nationwide. The findings imply a systematic measurement error that threatens any empirical work relying on county‑level overdose counts.

---

**3. Essential Points**  

| Issue | Why it matters | What to do |
|-------|----------------|------------|
| **A. Threat of endogenous placement of MDI systems** | The paper assumes the bordering choice of coroner vs. medical examiner is as‑good‑as random conditional on state‑year effects. Yet historical political, fiscal, or health‑service factors may have driven the institutional choice exactly where overdose risk differed (e.g., poorer, rural counties may have retained coroner systems). This could bias the “detection gap” upward or downward. | Conduct a more rigorous falsification exercise: (i) show that pre‑2003 overdose trends (or other health outcomes unrelated to forensic capacity) are statistically indistinguishable across bordering counties; (ii) include lagged overdose rates as controls; (iii) exploit a placebo outcome (e.g., accidental injury deaths) to demonstrate null effects. |
| **B. Use of model‑based NCHS mortality estimates** | The NCHS estimates are themselves smoothed across counties and may partially correct the very measurement error the paper aims to expose, potentially attenuating the estimated gap. | Provide a robustness check using raw WONDER counts where available (even if suppressed for small counties) and compare results; discuss the direction of any attenuation bias. |
| **C. Limited external validity of the border‑pair ATE** | The estimated effect applies only to counties that sit on a coroner/ME boundary in mixed states. Counties in uniformly coroner or ME states may differ systematically, so the national undercount extrapolation could be inaccurate. | Clarify the assumptions underlying the extrapolation; optionally, estimate a weighted average of the border‑pair effect and the full‑panel estimate (with appropriate controls) to bound the national undercount. Include a discussion of how heterogeneity across states (e.g., funding rules, toxicology capacity) may affect external validity. |

If any of these points cannot be adequately addressed, the paper should be **rejected** for lack of credible causal identification.

---

**4. Suggestions**  

1. **Strengthen the Identification Narrative**  
   - **Pre‑trend tests:** Plot overdose rates (or the unspecified‑death share if obtainable) for each side of the border over the 1999–2002 period, before the main opioid surge, to demonstrate parallel trends. Include formal tests (e.g., event‑study coefficients).  
   - **Placebo outcomes:** Use outcomes that should be unaffected by forensic capacity (e.g., mortality from chronic diseases, motor‑vehicle accidents) to reinforce that the observed gap is specific to drug‑overdose classification.  
   - **Instrumental‑variable angle (optional):** If data on historic county‑level funding for death investigation offices exist, they could serve as an instrument for current MDI type, further alleviating concerns about endogenous placement.

2. **Address Measurement‑Error Implications More Directly**  
   - **Explicit decomposition:** Show how the detection gap would translate into the share of T50.9 unspecified deaths using the CDC WONDER “Multiple Cause of Death” data for a subsample of counties where the detailed ICD‑10 codes are available (e.g., counties with >20 deaths). This can validate that the overall rate reduction corresponds to a shift toward unspecified coding.  
   - **Simulation of bias:** Conduct a Monte‑Carlo style simulation where the true overdose rate is known (e.g., from a high‑quality state like Massachusetts) and the observed rate is distorted by varying levels of misclassification. Demonstrate that the OLS coefficient approximates the true misclassification magnitude.

3. **Robustness to Alternative Fixed‑Effect Structures**  
   - **County‑by‑year trends:** Adding county‑specific linear time trends can control for divergent trajectories in drug use that are not captured by state‑year FE.  
   - **Spatial autocorrelation:** Test for spatial clustering of residuals (e.g., Moran’s I). If present, cluster standard errors at the state‑border level or use Conley spatial HAC corrections.

4. **Clarify the Role of the “Other” MDI Category**  
   - The paper excludes “Other County Official” counties, which comprise ~15 % of all counties. Explain whether these counties differ systematically (e.g., they may be “hybrid” systems) and whether their exclusion could bias the national estimate. A brief descriptive table would be helpful.

5. **Expand the Discussion of Policy Implications**  
   - **Funding formulas:** Cite specific federal allocation mechanisms that rely on county overdose counts (e.g., CDC’s Overdose Data to Action grant formulas).  
   - **Potential interventions:** Discuss concrete steps (e.g., federal grants for toxicology labs, standardized autopsy protocols) and cost‑benefit considerations, tying them back to the estimated 2,300 missed deaths.

6. **Presentation and Transparency**  
   - **Data and code availability:** Provide a reproducible replication package (e.g., a DOI‑linked GitHub repository) containing the merged dataset, code for constructing border pairs, and analysis scripts.  
   - **Table clarity:** In Table 1, indicate the number of counties after excluding the “Other” category and note the time span of the summary statistics. In Table 3 (robustness), report the number of observations for each sub‑sample to aid interpretation.  
   - **Notation consistency:** Define all variables when first used (e.g., “ODRate” in Equation 1). Ensure that the term “detection gap” is used consistently across text and tables.

7. **Minor Technical Corrections**  
   - The abstract states that coroner counties reported *lower* overdose rates “yet no one had died fewer times.” This wording could be interpreted as contradictory; consider rephrasing to emphasize the measurement issue.  
   - In the discussion of the temporal widening of the gap, citing the exact year when fentanyl‑related deaths overtook heroin would strengthen the narrative.  
   - Verify that the number of mixed states is 13 (as stated in the text) rather than 16 mentioned in the manifest; reconcile any discrepancy.

By addressing the three essential points—particularly the potential endogeneity of MDI placement and the implications of using smoothed mortality estimates—while incorporating the suggestions above, the manuscript will substantially improve its credibility and relevance. The research question is important, the data are rich, and the methodological framework is promising; with these refinements the paper can make a valuable contribution to the literature on measurement error in policy evaluation and to the design of more effective opioid‑response programs.
